685Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
France
Neuroscience Intelligence
France neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #2 of 50 · Data maturity A · Research score 52.6 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
171Recruiting trials
462Publications
592Institutions
Executive interpretation
France ranks #2 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Assistance Publique - Hôpitaux de Paris5113 recruiting
Hospices Civils de Lyon3514 recruiting
Merck Sharp & Dohme LLC238 recruiting
University Hospital, Montpellier234 recruiting
Hoffmann-La Roche226 recruiting
University Hospital, Toulouse193 recruiting
Assistance Publique Hopitaux De Marseille163 recruiting
University Hospital, Bordeaux166 recruiting
University Hospital, Strasbourg, France154 recruiting
University Hospital, Grenoble154 recruiting
Disease activity
Alzheimers117trials
Parkinsons112trials
Epilepsy100trials
Autism51trials
Other Neurology39trials
Depression39trials
Adhd27trials
Stroke19trials
Other Psychiatry19trials
Pain Neuropathy18trials
Research institutions
Biologie cellulaire et CancerOpenAlexlinked institution
Institut Pierre Louis d‘Épidémiologie et de Santé PubliqueOpenAlexlinked institution
Laboratoire de Génétique CellulaireOpenAlexlinked institution
École Normale Supérieure de LyonOpenAlexlinked institution
Générale de SantéOpenAlexlinked institution
Hôpital Arnaud de VilleneuveOpenAlexlinked institution
StromaLabOpenAlexlinked institution
Structure et Instabilité des GénomesOpenAlexlinked institution
Université Jean MonnetOpenAlexlinked institution
Ramsay Santé Hôpital privé des PeupliersOpenAlexlinked institution
Clinical evidence trail
NCT07888543Study of the Link Between Structural Alterations in the Hypothalamus and Cardiac Dysautonomia in Drug-resistant EpilepsyRECRUITING
NCT07819851A Study of the Correlation Between the Severity of Substance Use Disorder and the Intensity of Dependence on Generative Artificial IntelligenceNOT_YET_RECRUITING
NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07784595Comparison of an Initial Active Follow-up and Therapeutic Care on Functional Outcome and Quality of Life in Patients With Head and Neck ParagangliomasNOT_YET_RECRUITING
NCT07746050Value of Biomarkers of Brain Injury for Predicting Psycho-cognitive Sequelae Secondary to Sepsis: a Prospective Multicenter StudyNOT_YET_RECRUITING
NCT07740057Multimodal Study About Absence of Dp140 in Becker Muscular Dystrophy: Brain-muscle Imaging, Cognition and Muscle FunctionNOT_YET_RECRUITING
NCT07716982Estimation of Control Before and After Treatment of a Depressive Episode With Serotonin Reuptake InhibitorsNOT_YET_RECRUITING
NCT07686653A Study of the Value of Trio Genome Sequencing in the Etiological Evaluation of Early-Onset and/or Atypical Psychiatric Disorders Without Intellectual Disability or Congenital AnomaliesNOT_YET_RECRUITING
NCT07679087Study of the Frequency and Characteristics of Pain Symptoms in Restless Legs SyndromeNOT_YET_RECRUITING
NCT07579611Efficacy of Spinal Cord Stimulation in Chemotherapy-Induced Peripheral NeuropathyNOT_YET_RECRUITING
Research evidence trail
PUBMEDNetwork analysis of the link between depressive symptoms and risk of suicidal behavior at three years: A national prospective study.2026-12-15
PUBMEDRetinal electrophysiology in mood disorders: Toward clinically relevant biomarkers. A systematic review and meta-analysis.2026-12-15
PUBMEDA pilot randomized controlled trial of an integrative psychotherapy incorporating an attachment-based approach for adolescents with cannabis use disorder (TIMCA).2026-12-01
PUBMEDTraining community providers in prolonged exposure: outcomes of a French consultation programme.2026-12-01
PUBMEDMultimodal circadian phenotyping reveals distinct mechanisms of photic entrainment failure in two sighted patients with non-24-hour sleep-wake disorder.2026-12-01
PUBMEDImpact of prone positioning on sleep and respiratory outcomes by polysomnography in Robin Infants: a cross-sectional study.2026-12-01
PUBMEDConnectome-based graph metrics predict electroconvulsive therapy response in adults with depression.2026-12-01
PUBMEDTrauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series.2026-12-01
PUBMEDTherapeutic intensification in post-traumatic stress disorder worldwide: where do we stand?2026-12-01
PUBMEDToward an evolutionary and syndromic psychiatry: Dogs as a comparative model for the neuroscience of psychopathology.2026-12-01
PUBMEDD STRESS, an objective and efficient virtual reality-based tool to detect subthreshold PTSD in military population.2026-12-01
PUBMEDAssociation of smoking reduction with comorbid psychiatric symptoms including ADHD, depression, anxiety, and alcohol use disorder.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.